Radiofrequency Ablation of Leiomyomas.
Where this comes from
- Record sourced from PubMed, PMID 37053594.
- Also identified by DOI 10.1097/AOG.0000000000005196.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Radiofrequency ablation (RFA) of leiomyomas represents a significant advancement in the treatment of this common uterine condition. In the appropriately selected patient, both laparoscopic and transcervical options provide effective treatment for bleeding and bulk symptoms in a uterine-sparing manner. Compared with other minimally invasive leiomyoma treatment options, RFA procedures have comparable or favorable safety profiles, recovery timelines, and reintervention rates. Data on future fertility and pregnancy are limited, although early reports are promising.
Medical subject headings
- Uterine Neoplasms
- Catheter Ablation
- Leiomyoma
- Radiofrequency Ablation